Back
Speaker illustration

Doctor Pascal Burger

University Medical Center Utrecht, Utrecht (Netherlands (The))

Presentations

Effects of icosapent ethyl on residual cardiovascular risk according to predicted baseline risk: results from REDUCE-IT

Event: ESC Congress 2023

Topic: Drug therapy

Session: What's new in lipid lowering?

Access
Like
Thumbnail

Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: a meta-analysis of 59 trials

Event: ESC Congress 2023

Topic: Drug therapy

Session: What's new in lipid lowering?

Access
Like
Thumbnail

Inflammation and risk of recurrent cardiovascular events according to prior vascular disease location

Event: ESC Congress 2022

Topic: Secondary Prevention

Session: Secondary prevention 1

Access
Like
Thumbnail

Individual lifetime benefit from low-dose colchicine in chronic coronary artery disease patients

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Inflammation and coronary artery disease

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources